Carysil (CARYSIL)

FairStock Score: 38/100 — MIXED

Score breakdown: P/E: 1/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Net profit growth of 75.14% shows strong operating leverage and earnings momentum.
• Piotroski F-Score of 7/9 indicates sound financial health across operations and balance sheet.
• Debt/equity of 0.42 is conservative, giving flexibility during tough quarters.
• ROE of 15.08% and ROCE of 15.45% show reasonable capital efficiency.
• PEG of 0.66 suggests valuation is not excessive if current profit growth is sustainable.

Concerns

• P/E of 28.16 and P/B of 6.61 leave a thin margin of safety for a stock trading near ₹914.85.
• Sales growth of only 9.58% lags far behind profit growth of 75.14%, raising questions about earnings quality.
• Dividend yield of just 0.27% means shareholders depend almost entirely on capital appreciation.
• FairStock Score of 44/100 is mixed, and the wide 52-week range of ₹732.10-₹1280.00 highlights volatility.

AI Analysis

When I study Carysil, I try to view it as a business, not a ticker. The first thing that strikes me is the gap between sales and profits. Sales grew only 9.58%, yet profits jumped 75.14%. In Graham's language, that is a red flag until proven otherwise. Earnings can snap back when margin expansion is driven by one-off gains, just as quickly as they appeared. A P/E of 28.16 and P/B of 6.61 means the market is already paying for excellent performance, and with book value at ₹138.31 against ₹914.85, there is little asset support. The company earns a decent 15.08% ROE and 15.45% ROCE, and debt/equity of 0.42 is manageable. Piotroski F-Score of 7/9 suggests a healthy financial pulse. But 0.27% dividend yield tells me the return to shareholders is almost entirely dependent on future growth. The PEG of 0.66 is attractive only if profit growth continues; with sales rising low double digits, that is a big if. The latest quarter shows ₹223 Cr sales and ₹21 Cr net profit, roughly a 9.4% margin, so the operating story is real for now. FairStock Score at 44/100 is mixed, and the 52-week range of ₹732.10 to ₹1280.00 reminds me that this stock can test an investor's temperament. I would want clearer evidence that sales volume can accelerate before treating this as a definite fast grower. At the right price, the business merits study; at ₹914.85, I prefer to wait for a better margin of safety.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer